Home Featured Page 180

Featured

Latest

Burning Heroes Pitch Competition

Psilocybin for Cocaine Use Disorder: Peter Hendricks on a Trial Ten Years in the Making

Pα+ Psychedelic Bulletin #224: Reactions to Trump’s Psychedelics Executive Order, and What Comes Next; Pre-EO, DEA Poured Cold Water on Right to Try

God, Gabon, and Government: W. Bryan Hubbard on Ibogaine, the Executive Order, and What Comes Next

Psychedelic Bulletin #106 – DMT Study Skips Set and Setting; Cybin...

Kambô: Another Psychedelic Amphibian?

PT326 – Dr. Rick Barnett, Psy.D – Addiction, Recovery, and Competency...

PT325 – Philip Wolf – Cannabis: The Early Days of Legality,...

The Intertwined Prohibitionist Histories of Psychedelics and Kratom

Psychedelic Bulletin #105 – UK Won’t Foot the Bill for Spravato;...

PT324 – Amanda Reiman, Ph.D., MSW – Web3, NFTs, Cryptocurrencies, and...

Psychedelic Research Bulletin: May 2022

PT323 – Dr. Reid Robison & Steve Thayer, Ph.D. – Ketamine-Assisted...

Psychedelic Bulletin #104 – Mydecine CEO Downplays Insider Activity; UC Davis...

EDITOR PICKS

Burning Heroes Pitch Competition

Psilocybin for Cocaine Use Disorder: Peter Hendricks on a Trial Ten...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Burning Heroes Pitch Competition

No Promises and No Goals

Psilocybin for Cocaine Use Disorder: Peter Hendricks on a Trial Ten Years in the Making

Pα+ Psychedelic Bulletin #224: Reactions to Trump’s Psychedelics Executive Order, and What Comes Next; Pre-EO, DEA Poured Cold Water on Right to Try

God, Gabon, and Government: W. Bryan Hubbard on Ibogaine, the Executive Order, and What Comes Next

Psychedelic Bulletin #106 – DMT Study Skips Set and Setting; Cybin...

Kambô: Another Psychedelic Amphibian?

PT326 – Dr. Rick Barnett, Psy.D – Addiction, Recovery, and Competency...

PT325 – Philip Wolf – Cannabis: The Early Days of Legality,...

The Intertwined Prohibitionist Histories of Psychedelics and Kratom

Psychedelic Bulletin #105 – UK Won’t Foot the Bill for Spravato;...

PT324 – Amanda Reiman, Ph.D., MSW – Web3, NFTs, Cryptocurrencies, and...

Psychedelic Research Bulletin: May 2022

PT323 – Dr. Reid Robison & Steve Thayer, Ph.D. – Ketamine-Assisted...

Psychedelic Bulletin #104 – Mydecine CEO Downplays Insider Activity; UC Davis...

EDITOR PICKS

Burning Heroes Pitch Competition

No Promises and No Goals

Psilocybin for Cocaine Use Disorder: Peter Hendricks on a Trial Ten...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY